IMGN Income Statement

Click line-items for a historical chart and %
Revenues:
Research and development support 2.26M
License and milestone fees 22.01M
Clinical materials reimbursement 734K
Total revenues 25M
Operating Expenses:
Research and development 21.32M
General and administrative 5M
Total operating expenses 26.31M
Loss from operations -1.31M
Other (expense) income, net -39K
Loss before provision for income taxes
Net loss -1.35M
Basic and diluted net loss per common share (in dollars per share) -0.02
Basic weighted average common shares outstanding (in shares)
Diluted weighted average common shares outstanding (in shares)

Entities mentioned with IMGN

View All Entities